Peppermint

Metadata

• Common Names: Peppermint (English), Pfefferminze (German)
• Botanical Name: Mentha x piperita L.
• Plant Family: Lamiaceae (Labiatae)
• Part Used: Leaf (Menthae piperitae folium); Essential oil (Menthae piperitae aetheroleum)
• Evidence Quality Rating: Strong

Approved Indications

Commission E

• Leaf: Spastic complaints of the gastrointestinal tract; gallbladder and bile duct conditions
• Oil: Spastic discomfort of the upper gastrointestinal tract and bile ducts; irritable bowel syndrome; catarrhs of the upper respiratory tract; myalgia and neuralgia (topical)

ESCOP

• Symptomatic relief of digestive disorders including flatulence, dyspepsia, and gastritis
• Irritable bowel syndrome (enteric-coated peppermint oil)
• Catarrhs of the upper respiratory tract
• Topical: Tension headache, myalgia

EMA/HMPC

• Well-established use (oil): Relief of symptoms in IBS (enteric-coated capsules)
• Traditional use (leaf): Relief of minor spasms of the GI tract, flatulence, and abdominal pain
• Traditional use (oil): Symptomatic relief of minor digestive complaints including bloating and flatulence; symptomatic relief of cough and cold; relief of localized muscle pain
• The IBS indication is one of the few herbal applications granted “well-established use” status by the EMA

Agreement/Disagreement Between Bodies

• All three bodies agree on GI antispasmodic and carminative properties
• All three specifically endorse peppermint oil for IBS — a notably strong consensus
• The EMA distinguishes between well-established use (IBS with enteric-coated oil) and traditional use (general dyspepsia) — this distinction is clinically important
• Commission E gives the broadest scope including bile duct conditions
• ESCOP and EMA are closely aligned

Conditions Treated

• Irritable bowel syndrome (IBS)
• Functional dyspepsia
• Abdominal pain / GI spasms
• Flatulence / Bloating
• Nausea
• Bile duct spasm
• Tension headache (topical)
• Upper respiratory catarrh

Mechanism of Action

• Menthol (primary active, 30-55% of essential oil): Blocks voltage-gated calcium channels in GI smooth muscle cells, producing direct antispasmodic effect; activates TRPM8 cold receptors producing analgesic effect; reduces visceral hypersensitivity
• Menthone: Contributing antispasmodic and antimicrobial activity
• Smooth muscle relaxation: Dose-dependent inhibition of calcium influx through L-type calcium channels in intestinal smooth muscle, analogous to calcium channel blockers
• Visceral sensitivity modulation: Activation of kappa-opioid receptors and TRPM8 channels in colonic sensory neurons reduces pain signaling
• Anti-inflammatory activity: Inhibition of pro-inflammatory cytokines (TNF-alpha, IL-6) in intestinal tissue
• Antimicrobial effects: Broad-spectrum activity against gut pathogens including H. pylori
• Bile stimulation: Mild choleretic and cholagogue activity

Clinical Evidence Summary

IBS — Multiple Meta-Analyses

• Alammar et al. (2019): Meta-analysis of 12 RCTs; peppermint oil significantly superior to placebo for global IBS symptoms (RR=2.39, 95% CI: 1.93-2.97) with NNT=3 for enteric-coated formulations [BMC Complement Med Ther]
• Ingrosso et al. (2022): Systematic review and meta-analysis of 10 RCTs (n=1030); peppermint oil more efficacious than placebo for global IBS symptoms (RR of not improving=0.65, 95% CI: 0.43-0.98, NNT=4) and abdominal pain (RR=0.76, 95% CI: 0.62-0.93, NNT=7) [Aliment Pharmacol Ther]
• Khanna et al. (2014): Meta-analysis of 9 RCTs (n=726); peppermint oil was significantly superior to placebo for global improvement (RR=2.23) and abdominal pain (RR=2.14) [J Clin Gastroenterol]
• Quality of evidence generally rated low to moderate due to heterogeneity and risk of bias; however, consistent direction of effect across all meta-analyses strengthens confidence

Functional Dyspepsia

• Peppermint oil in combination with caraway oil (Enteroplant: 90mg peppermint oil + 50mg caraway oil) studied in multiple RCTs
• Comparable efficacy to cisapride in relieving dyspepsia
• Significant reduction in postprandial distress syndrome and epigastric pain

Guideline Recommendations

• Recommended by European, Canadian, and Japanese clinical practice guidelines for IBS symptom relief
• American College of Gastroenterology (ACG) 2021 guidelines: conditional recommendation for peppermint oil in IBS (moderate quality evidence)

European vs US/Anglophone Consensus

• Unusual consensus: Both European and US/Anglophone authorities recognize peppermint oil for IBS
• The ACG 2021 IBS guideline conditionally recommends peppermint oil — rare for a herbal product in US gastroenterology guidelines
• In Germany, peppermint oil (enteric-coated) is a standard pharmacy product prescribed by gastroenterologists
• In the US, peppermint oil for IBS is increasingly mainstream but still often categorized as “complementary” medicine
• The peppermint-caraway combination (Enteroplant) is well known in Germany but virtually unknown in US clinical practice
• Peppermint tea is used casually in both traditions but only enteric-coated oil has robust trial support for IBS

Safety Profile

Contraindications

• Gastroesophageal reflux disease (GERD): Peppermint oil relaxes the lower esophageal sphincter, potentially worsening reflux
• Achlorhydria: Enteric-coated capsules may dissolve prematurely
• Bile duct obstruction
• Gallstones (Commission E notes caution)
• Severe liver disease
• Children under 8 years: Menthol can cause breathing problems, laryngospasm, or bronchospasm in infants and young children

Drug Interactions

• May cause premature dissolution of enteric coating if taken with antacids, H2 blockers, or PPIs (take separately by 2 hours)
• Theoretical CYP1A2 and CYP3A4 inhibition by menthol (clinical significance uncertain)
• Potential additive effect with other calcium channel blockers
• Cyclosporine levels may be increased (case reports)

Side Effects

• Heartburn / acid reflux (most common — up to 10% incidence in clinical trials; reduced with enteric-coated formulations)
• Perianal burning sensation
• Nausea (uncommon)
• Allergic reactions (rare)
• Adverse event rates significantly higher with peppermint oil vs placebo in meta-analysis (RR=1.57, 95% CI: 1.04-2.37) — but events were generally mild

Pregnancy/Lactation

• Peppermint leaf tea is generally regarded as safe during pregnancy in moderate amounts
• Peppermint oil in therapeutic doses: insufficient safety data in pregnancy; use with caution
• High doses theoretically could trigger menstruation (emmenagogue effect)
• Compatible with breastfeeding in usual food/tea amounts

Clinical Dosage

Enteric-Coated Peppermint Oil (IBS)

• Standard dose: 0.2-0.4 mL (182-364 mg) peppermint oil per capsule, 1-2 capsules 2-3 times daily
• Typical trial dose: 187 mg per capsule (0.2 mL), three times daily before meals for 4-8 weeks
• Must be enteric-coated to avoid gastric dissolution and reflux side effects
• Products: Colpermin (UK), Mintec (Australia), IBgard (US — microsphere technology)

Peppermint-Caraway Combination (Dyspepsia)

• Enteroplant: 90 mg peppermint oil + 50 mg caraway oil, enteric-coated, 1 capsule 2-3 times daily for up to 4 weeks

Peppermint Leaf

• Tea: 1.5-3 g dried leaf per 150 mL, steeped 5-10 minutes, 3-4 times daily
• Tincture (1:5): 2-3 mL three times daily

Sources

• EMA/HMPC Herbal Monograph on Mentha x piperita L., folium and aetheroleum
• Commission E Monograph: Menthae piperitae aetheroleum; Menthae piperitae folium
• ESCOP Monographs: Menthae piperitae folium; Menthae piperitae aetheroleum
• Alammar N, et al. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis. BMC Complement Med Ther. 2019;19:21
• Ingrosso MR, et al. Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome. Aliment Pharmacol Ther. 2022;56(6):932-941
• Khanna R, MacDonald JK, Levesque BG. Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Clin Gastroenterol. 2014;48(6):505-512
• Kligler B, Chaudhary S. Peppermint oil. Am Fam Physician. 2007;75(7):1027-1030
• Lacy BE, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021;116(1):17-44
• Cash BD, Epstein MS, Shah SM. A novel delivery system of peppermint oil is an effective therapy for irritable bowel syndrome symptoms. Dig Dis Sci. 2016;61:560-571

Connections

• Component of STW 5/Iberogast multi-herb combination
• Combined with Caraway in Enteroplant for functional dyspepsia
• Compare with German Chamomile for GI antispasmodic applications
• One of the strongest evidence bases among all GI herbs studied in this collection